Bio-inspired, bioengineered and biomimetic drug delivery carriers (original) (raw)

• Allen, T. M. & Cullis, P. R. Drug delivery systems: entering the mainstream. Science 303, 1818–1822 (2004).
  Article CAS PubMed Google Scholar
• Farokhzad, O. C. & Langer, R. Impact of nanotechnology on drug delivery. ACS Nano 3, 16–20 (2009).
  Article CAS PubMed Google Scholar
• Langer, R. New methods of drug delivery. Science 249, 1527–1533 (1990).
  Article CAS PubMed Google Scholar
• Moghimi, S. M. & Kissel, T. Particulate nanomedicines. Adv. Drug Deliv. Rev. 58, 1451–1455 (2006).
  Article CAS PubMed Google Scholar
• Alcami, A. & Koszinowski, U. H. Viral mechanisms of immune evasion. Immunol. Today 21, 447–455 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Ploegh, H. L. Viral strategies of immune evasion. Science 280, 248–253 (1998).
  Article CAS PubMed Google Scholar
• Mudhakir, D. & Harashima, H. Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus. AAPS J. 11, 65–77 (2009).
  Article PubMed PubMed Central Google Scholar
• Hornef, M. W., Wick, M. J., Rhen, M. & Normark, S. Bacterial strategies for overcoming host innate and adaptive immune responses. Nature Immunol. 3, 1033–1040 (2002).
  Article CAS Google Scholar
• Wells, J. M. & Mercenier, A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nature Rev. Microbiol. 6, 349–362 (2008). An overview of the use of recombinant GRAS bacteria for drug delivery.
  Article CAS Google Scholar
• Wells, J. Mucosal vaccination and therapy with genetically modified lactic acid bacteria. Annu. Rev. Food Sci. Technol. 2, 423–445 (2011).
  Article CAS PubMed Google Scholar
• Yuvaraj, S., Peppelenbosch, M. P. & Bos, N. A. Transgenic probiotica as drug delivery systems: the golden bullet? Expert Opin. Drug Deliv. 4, 1–3 (2007).
  Article CAS PubMed Google Scholar
• Steidler, L. et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nature Biotech. 21, 785–789 (2003).
  Article CAS Google Scholar
• Steidler, L. et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin10. Science 289, 1352–1355 (2000). This study demonstrated the in vivo delivery of therapeutic proteins that were produced by recombinant bacteria for the treatment of a specific disease.
  Article CAS PubMed Google Scholar
• Braat, H. et al. A phase I trial with transgenic bacteria expressing interleukin10 in Crohn's disease. Clin. Gastroenterol. Hepatol. 4, 754–759 (2006).
  Article CAS PubMed Google Scholar
• Caluwaerts, S. et al. AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis. Oral Oncol. 46, 564–570 (2010).
  Article CAS PubMed Google Scholar
• Ricci, S. et al. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii. BMC Biotechnol. 3, 15 (2003).
  Article PubMed PubMed Central Google Scholar
• Porzio, S., Bossu, P., Ruggiero, P., Boraschi, D. & Tagliabue, A. Mucosal delivery of anti-inflammatory IL1-Ra by sporulating recombinant bacteria. BMC Biotechnol. 4, 27 (2004).
  Article PubMed PubMed Central CAS Google Scholar
• Pusch, O. et al. Bioengineering lactic acid bacteria to secrete the HIV1 virucide cyanovirin. J. Acquir. Immune Defic. Syndr. 40, 512–520 (2005).
  Article CAS PubMed Google Scholar
• Pusch, O. et al. An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV1 fusion inhibitors by lactobacilli. AIDS 20, 1917–1922 (2006).
  Article CAS PubMed Google Scholar
• Liu, X. et al. Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N. Antimicrob. Agents Chemother. 50, 3250–3259 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Robinson, K. et al. Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infect. Immun. 72, 2753–2761 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Hanniffy, S. B., Carter, A. T., Hitchin, E. & Wells, J. M. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J. Infect. Dis. 195, 185–193 (2007).
  Article CAS PubMed Google Scholar
• Poo, H. et al. Oral administration of human papilloma virus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice. Int. J. Cancer 119, 1702–1709 (2006).
  Article CAS PubMed Google Scholar
• Mohamadzadeh, M., Duong, T., Sandwick, S. J., Hoover, T. & Klaenhammer, T. R. Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge. Proc. Natl Acad. Sci. USA 106, 4331–4336 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Cheminay, C. & Hensel, M. Rational design of Salmonella recombinant vaccines. Int. J. Med. Microbiol. 298, 87–98 (2008).
  Article CAS PubMed Google Scholar
• Pawelek, J. M., Low, K. B. & Bermudes, D. Bacteria as tumour-targeting vectors. Lancet Oncol. 4, 548–556 (2003).
  Article PubMed Google Scholar
• King, I. et al. Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent. Hum. Gene Ther. 13, 1225–1233 (2002).
  Article CAS PubMed Google Scholar
• Low, K. B. et al. Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo. Nature Biotech. 17, 37–41 (1999).
  Article CAS Google Scholar
• Pawelek, J. M., Low, K. B. & Bermudes, D. Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res. 57, 4537–4544 (1997).
  CAS PubMed Google Scholar
• Schlechte, H. & Elbe, B. Recombinant plasmid DNA variation of Clostridium oncolyticum — model experiments of cancerostatic gene transfer. Zentralbl. Bakteriol. Mikrobiol. Hyg. A 268, 347–356 (1988).
  CAS PubMed Google Scholar
• Jiang, Z. et al. Using attenuated Salmonella typhi as tumor targeting vector for MDR1 siRNA delivery. Cancer Biol. Ther. 6, 555–560 (2007).
  Article CAS PubMed Google Scholar
• Zhang, L. et al. Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs. Cancer Res. 67, 5859–5864 (2007).
  Article CAS PubMed Google Scholar
• Xiang, S., Fruehauf, J. & Li, C. J. Short hairpin RNA-expressing bacteria elicit RNA interference in mammals. Nature Biotech. 24, 697–702 (2006). This study demonstrated that RNAi mediated by recombinant bacteria induces gene silencing in mammalian cells.
  Article CAS Google Scholar
• Akin, D. et al. Bacteria-mediated delivery of nanoparticles and cargo into cells. Nature Nanotechnol. 2, 441–449 (2007). This was a report on a novel technique for delivering nanoparticles, which are carried on the bacterial surface.
  Article CAS Google Scholar
• Witte, A., Wanner, G., Sulzner, M. & Lubitz, W. Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli. Arch. Microbiol. 157, 381–388 (1992).
  Article CAS PubMed Google Scholar
• Lubitz, P., Mayr, U. B. & Lubitz, W. Applications of bacterial ghosts in biomedicine. Adv. Exp. Med. Biol. 655, 159–170 (2009).
  Article CAS PubMed Google Scholar
• Kudela, P. et al. Bacterial ghosts as novel efficient targeting vehicles for DNA delivery to the human monocyte-derived dendritic cells. J. Immunother. 28, 136–143 (2005).
  Article CAS PubMed Google Scholar
• Paukner, S. et al. DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages. Mol. Ther. 11, 215–223 (2005).
  Article CAS PubMed Google Scholar
• Paukner, S., Kohl, G. & Lubitz, W. Bacterial ghosts as novel advanced drug delivery systems: antiproliferative activity of loaded doxorubicin in human Caco2 cells. J. Control Release 94, 63–74 (2004).
  Article CAS PubMed Google Scholar
• Talebkhan, Y. et al. Helicobacter pylori bacterial ghost containing recombinant Omp18 as a putative vaccine. J. Microbiol. Methods 82, 334–337 (2010).
  Article CAS PubMed Google Scholar
• Eko, F. O., Talin, B. A. & Lubitz, W. Development of a Chlamydia trachomatis bacterial ghost vaccine to fight human blindness. Hum. Vaccin. 4, 176–183 (2008).
  Article CAS PubMed Google Scholar
• Kudela, P., Koller, V. J. & Lubitz, W. Bacterial ghosts (BGs) — advanced antigen and drug delivery system. Vaccine 28, 5760–5767 (2010).
  Article CAS PubMed Google Scholar
• van Roosmalen, M. L. et al. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria. Methods 38, 144–149 (2006).
  Article CAS PubMed Google Scholar
• Audouy, S. A. et al. Development of lactococcal GEM-based pneumococcal vaccines. Vaccine 25, 2497–2506 (2007).
  Article CAS PubMed Google Scholar
• Nuyts, S. et al. Clostridium spores for tumor-specific drug delivery. Anticancer Drugs 13, 115–125 (2002).
  Article CAS PubMed Google Scholar
• Toso, J. F. et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J. Clin. Oncol. 20, 142–152 (2002).
  Article PubMed Google Scholar
• Schnierle, B. S. et al. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl Acad. Sci. USA 94, 8640–8645 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Pereboev, A. V. et al. Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule. Mol. Ther. 9, 712–720 (2004).
  Article CAS PubMed Google Scholar
• Everts, M. et al. Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy. Nano Lett. 6, 587–591 (2006). This was a demonstration of the use of gold nanoparticles that were attached to the surface of a viral vector for selective delivery to tumour cells, thus implicating the possibility of photothermal therapy and gene therapy as a combinational therapeutic approach.
  Article CAS PubMed Google Scholar
• Saini, V. et al. An adenoviral platform for selective self-assembly and targeted delivery of nanoparticles. Small 4, 262–269 (2008).
  Article CAS PubMed Google Scholar
• Huh, Y. et al. Hybrid nanoparticles for magnetic resonance imaging of target-specific viral gene delivery. Adv. Mater. 19, 3109–3112 (2007).
  Article CAS Google Scholar
• You, J. O., Liu, Y. S., Liu, Y. C., Joo, K. I. & Peng, C. A. Incorporation of quantum dots on virus in polycationic solution. Int. J. Nanomedicine 1, 59–64 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Grgacic, E. V. & Anderson, D. A. Virus-like particles: passport to immune recognition. Methods 40, 60–65 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Villa, L. L. et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 6, 271–278 (2005).
  Article PubMed Google Scholar
• Garland, S. M. et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N. Engl. J. Med. 356, 1928–1943 (2007).
  Article CAS PubMed Google Scholar
• Wang, M. et al. Inhibition of simian virus 40 large tumor antigen expression in human fetal glial cells by an antisense oligodeoxynucleotide delivered by the JC virus-like particle. Hum. Gene Ther. 15, 1077–1090 (2004).
  Article CAS PubMed Google Scholar
• Henke, S., Rohmann, A., Bertling, W. M., Dingermann, T. & Zimmer, A. Enhanced in vitro oligonucleotide and plasmid DNA transport by VP1 virus-like particles. Pharm. Res. 17, 1062–1070 (2000).
  Article CAS PubMed Google Scholar
• Pattenden, L. K., Middelberg, A. P., Niebert, M. & Lipin, D. I. Towards the preparative and large-scale precision manufacture of virus-like particles. Trends Biotechnol. 23, 523–529 (2005).
  Article CAS PubMed Google Scholar
• Datta, A. et al. High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents. J. Am. Chem. Soc. 130, 2546–2552 (2008).
  Article CAS PubMed Google Scholar
• Tong, G. J., Hsiao, S. C., Carrico, Z. M. & Francis, M. B. Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles. J. Am. Chem. Soc. 131, 11174–11178 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hooker, J. M., O'Neil, J. P., Romanini, D. W., Taylor, S. E. & Francis, M. B. Genome-free viral capsids as carriers for positron emission tomography radiolabels. Mol. Imaging Biol. 10, 182–191 (2008).
  Article PubMed Google Scholar
• Wu, W., Hsiao, S. C., Carrico, Z. M. & Francis, M. B. Genome-free viral capsids as multivalent carriers for taxol delivery. Angew. Chem. Int. Ed. Engl. 48, 9493–9497 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Seow, Y. & Wood, M. J. Biological gene delivery vehicles: beyond viral vectors. Mol. Ther. 17, 767–777 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Takamura, S. et al. DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration. Gene Ther. 11, 628–635 (2004).
  Article CAS PubMed Google Scholar
• May, T., Gleiter, S. & Lilie, H. Assessment of cell type specific gene transfer of polyoma virus like particles presenting a tumor specific antibody Fv fragment. J. Virol. Methods 105, 147–157 (2002).
  Article CAS PubMed Google Scholar
• Manchester, M. & Singh, P. Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging. Adv. Drug Deliv. Rev. 58, 1505–1522 (2006).
  Article CAS PubMed Google Scholar
• Strable, E. & Finn, M. G. Chemical modification of viruses and virus-like particles. Curr. Top. Microbiol. Immunol. 327, 1–21 (2009).
  CAS PubMed Google Scholar
• Sengupta, S. et al. Accelerated bioorthogonal conjugation: a practical method for the ligation of diverse functional molecules to a polyvalent virus scaffold. Bioconjug. Chem. 16, 1572–1579 (2005).
  Article CAS Google Scholar
• Almeida, J. D., Edwards, D. C., Brand, C. M. & Heath, T. D. Formation of virosomes from influenza subunits and liposomes. Lancet 2, 899–901 (1975).
  Article CAS PubMed Google Scholar
• de Jonge, J. et al. Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA. Biochem. J. 405, 41–49 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Daemen, T. et al. Virosomes for antigen and DNA delivery. Adv. Drug Deliv. Rev. 57, 451–463 (2005).
  Article CAS PubMed Google Scholar
• Lakadamyali, M., Rust, M. J. & Zhuang, X. Endocytosis of influenza viruses. Microbes Infect. 6, 929–936 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Earp, L. J., Delos, S. E., Park, H. E. & White, J. M. The many mechanisms of viral membrane fusion proteins. Curr. Top. Microbiol. Immunol. 285, 25–66 (2005).
  CAS PubMed PubMed Central Google Scholar
• Leroux-Roels, G. Unmet needs in modern vaccinology adjuvants to improve the immune response. Vaccine 28 (Suppl. 3), 25–36 (2010).
  Article Google Scholar
• Chams, V., Bonnafous, P. & Stegmann, T. Influenza hemagglutinin mediated fusion of membranes containing poly(ethylene-glycol) grafted lipids: new insights into the fusion mechanism. FEBS Lett. 448, 28–32 (1999).
  Article CAS PubMed Google Scholar
• Waelti, E. et al. Targeting HER-2/neu with antirat Neu virosomes for cancer therapy. Cancer Res. 62, 437–444 (2002).
  CAS PubMed Google Scholar
• de Jonge, J., Holtrop, M., Wilschut, J. & Huckriede, A. Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs. Gene Ther. 13, 400–411 (2006).
  Article CAS PubMed Google Scholar
• Hubbell, J. A., Thomas, S. N. & Swartz, M. A. Materials engineering for immunomodulation. Nature 462, 449–460 (2009).
  Article CAS PubMed Google Scholar
• Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B. & Rock, K. L. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl Acad. Sci. USA 90, 4942–4946 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Reis e Sousa, C. & Germain, R. N. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 182, 841–851 (1995).
  Article CAS PubMed Google Scholar
• Serre, K., Giraudo, L., Siret, C., Leserman, L. & Machy, P. CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo. Eur. J. Immunol. 36, 1386–1397 (2006).
  Article CAS PubMed Google Scholar
• Harding, C. V., Collins, D. S., Slot, J. W., Geuze, H. J. & Unanue, E. R. Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell 64, 393–401 (1991).
  Article CAS PubMed Google Scholar
• Shen, H. et al. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology 117, 78–88 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Junt, T. et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 450, 110–114 (2007).
  Article CAS PubMed Google Scholar
• Manolova, V. et al. Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 38, 1404–1413 (2008).
  Article CAS PubMed Google Scholar
• Reddy, S. T. et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nature Biotech. 25, 1159–1164 (2007).
  Article CAS Google Scholar
• Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805–820 (2010).
  Article CAS PubMed Google Scholar
• van Duin, D., Medzhitov, R. & Shaw, A. C. Triggering TLR signaling in vaccination. Trends Immunol. 27, 49–55 (2006).
  Article CAS PubMed Google Scholar
• Blander, J. M. & Medzhitov, R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440, 808–812 (2006).
  Article CAS PubMed Google Scholar
• Heit, A., Schmitz, F., Haas, T., Busch, D. H. & Wagner, H. Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity. Eur. J. Immunol. 37, 2063–2074 (2007).
  Article CAS PubMed Google Scholar
• Demento, S. L. et al. TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis. J. Immunol. 185, 2989–2997 (2010).
  Article CAS PubMed Google Scholar
• Alving, C. R. & Rao, M. Lipid A and liposomes containing lipid A as antigens and adjuvants. Vaccine 26, 3036–3045 (2008).
  Article CAS PubMed Google Scholar
• Bershteyn, A. et al. Polymer-supported lipid shells, onions, and flowers. Soft Matter 4, 1787–1791 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Brodsky, I. E. & Monack, D. NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens. Semin. Immunol. 21, 199–207 (2009).
  Article CAS PubMed Google Scholar
• Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nature Immunol. 9, 847–856 (2008).
  Article CAS Google Scholar
• Eisenbarth, S. C., Colegio, O. R., O'Connor, W., Sutterwala, F. S. & Flavell, R. A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453, 1122–1126 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Sharp, F. A. et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc. Natl Acad. Sci. USA 106, 870–875 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Malyala, P., O'Hagan, D. T. & Singh, M. Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles. Adv. Drug Deliv. Rev. 61, 218–225 (2009).
  Article CAS PubMed Google Scholar
• Xu, L. et al. Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene delivery. Hum. Gene Ther. 13, 469–481 (2002). This study described a virus-mimetic synthetic system that resembles the structural and functional traits of a virus.
  Article CAS PubMed Google Scholar
• Lee, E. S., Kim, D., Youn, Y. S., Oh, K. T. & Bae, Y. H. A virus-mimetic nanogel vehicle. Angew. Chem. Int. Ed. Engl. 47, 2418–2421 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Geng, Y. et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nature Nanotechnol. 2, 249–255 (2007).
  Article CAS Google Scholar
• Muzykantov, V. R. Drug delivery by red blood cells: vascular carriers designed by mother nature. Expert Opin. Drug Deliv. 7, 403–427 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Hamidi, M., Zarrin, A., Foroozesh, M. & Mohammadi-Samani, S. Applications of carrier erythrocytes in delivery of biopharmaceuticals. J. Control Release 118, 145–160 (2007).
  Article CAS PubMed Google Scholar
• Gopal, V., Kumar, A., Usha, A., Karthik, A. & Udupa, N. Effective drug targeting by erythrocytes as carrier systems. Curr. Trends Biotechnol. Pharm. 1, 18–33 (2007).
  CAS Google Scholar
• Fraternale, A. et al. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. Antiviral Res. 56, 263–272 (2002).
  Article CAS PubMed Google Scholar
• Talwar, N. & Jain, N. Erythrocytes as carriers of metronidazole: in vitro characterization. Drug Dev. Ind. Pharm. 18, 1799–1812 (1992).
  Article CAS Google Scholar
• Kravtzoff, R., Ropars, C., Laguerre, M., Muh, J. & Chassaigne, M. Erythrocytes as carriers for L-asparaginase. Methodological and mouse in-vivo studies. J. Pharm. Pharmacol. 42, 473 (1990).
  Article CAS PubMed Google Scholar
• Annese, V. et al. Erythrocytes-mediated delivery of dexamethasone in steroid-dependent IBD patients — a pilot uncontrolled study. Am. J. Gastroenterol. 100, 1370–1375 (2005).
  Article CAS PubMed Google Scholar
• Hamidi, M., Tajerzadeh, H., Dehpour, A. R., Rouini, M. R. & Ejtemaee-Mehr, S. In vitro characterization of human intact erythrocytes loaded by enalaprilat. Drug Deliv. 8, 223–230 (2001).
  Article CAS PubMed Google Scholar
• Lotero, L. A., Olmos, G. & Diez, J. C. Delivery to macrophages and toxic action of etoposide carried in mouse red blood cells. Biochim. Biophys. Acta 1620, 160–166 (2003).
  Article CAS PubMed Google Scholar
• Kim, S. H. et al. Opsonized erythrocyte ghosts for liver-targeted delivery of antisense oligodeoxynucleotides. Biomaterials 30, 959–967 (2009).
  Article PubMed CAS Google Scholar
• Flynn, G., McHale, L. & McHale, A. P. Methotrexate-loaded, photosensitized erythrocytes: a photo-activatable carrier/delivery system for use in cancer therapy. Cancer Lett. 82, 225–229 (1994).
  Article CAS PubMed Google Scholar
• Jain, S., Jain, S. K. & Dixit, V. Magnetically guided rat erythrocytes bearing isoniazid: preparation, characterization, and evaluation. Drug Dev. Ind. Pharm. 23, 999–1006 (1997).
  Article CAS Google Scholar
• Chiarantini, L., Rossi, L., Fraternale, A. & Magnani, M. Modulated red blood cell survival by membrane protein clustering. Mol. Cell Biochem. 144, 53–59 (1995).
  Article CAS PubMed Google Scholar
• Chambers, E. & Mitragotri, S. Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes. J. Control Release 100, 111–119 (2004).
  Article CAS PubMed Google Scholar
• Chambers, E. & Mitragotri, S. Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation. Exp. Biol. Med. (Maywood) 232, 958–966 (2007).
  CAS Google Scholar
• Murciano, J. C. et al. Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes. Nature Biotech. 21, 891–896 (2003).
  Article CAS Google Scholar
• Danielyan, K. et al. Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator. Circulation 118, 1442–1449 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Zaitsev, S. et al. Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis. Blood 108, 1895–1902 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Burke, B., Sumner, S., Maitland, N. & Lewis, C. E. Macrophages in gene therapy: cellular delivery vehicles and in vivo targets. J. Leukoc. Biol. 72, 417–428 (2002).
  CAS PubMed Google Scholar
• Dou, H. et al. Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Blood 108, 2827–2835 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, Y. et al. Ingress of blood-borne macrophages across the blood–brain barrier in murine HIV1 encephalitis. J. Neuroimmunol. 200, 41–52 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Dou, H. et al. Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J. Immunol. 183, 661–669 (2009).
  Article CAS PubMed Google Scholar
• Bingle, L., Brown, N. J. & Lewis, C. E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196, 254–265 (2002).
  Article CAS PubMed Google Scholar
• Choi, M. R. et al. A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. Nano Lett. 7, 3759–3765 (2007). This was the first study of photothermal therapy that used TAMs as delivery carriers of gold nanoshells.
  Article CAS PubMed Google Scholar
• Alizadeh, D., Zhang, L., Hwang, J., Schluep, T. & Badie, B. Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas. Nanomedicine 6, 382–390 (2009).
  Article PubMed CAS Google Scholar
• Murdoch, C., Giannoudis, A. & Lewis, C. E. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104, 2224–2234 (2004).
  Article CAS PubMed Google Scholar
• Swiston, A. J. et al. Surface functionalization of living cells with multilayer patches. Nano Lett. 8, 4446–4453 (2008).
  Article CAS PubMed Google Scholar
• Swiston, A. J., Gilbert, J. B., Irvine, D. J., Cohen, R. E. & Rubner, M. F. Freely suspended cellular “backpacks” lead to cell aggregate self-assembly. Biomacromolecules 11, 1826–1832 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Stephan, M. T., Moon, J. J., Um, S. H., Bershteyn, A. & Irvine, D. J. Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nature Med. 16, 1035–1041 (2010).
  Article CAS PubMed Google Scholar
• Rosenberg, S. A., Restifo, N. P., Yang, J. C., Morgan, R. A. & Dudley, M. E. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nature Rev. Cancer 8, 299–308 (2008).
  Article CAS Google Scholar
• June, C. Principles of adoptive T cell cancer therapy. J. Clin. Invest. 117, 1204–1212 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Studeny, M. et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J. Natl Cancer Inst. 96, 1593–1603 (2004).
  Article CAS PubMed Google Scholar
• Studeny, M. et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-β delivery into tumors. Cancer Res. 62, 3603–3608 (2002).
  CAS PubMed Google Scholar
• Nakamizo, A. et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 65, 3307–3318 (2005).
  Article CAS PubMed Google Scholar
• Ren, C. et al. Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model. Gene Ther. 15, 1446–1453 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Ren, C. et al. Therapeutic potential of mesenchymal stem cells producing interferon-α in a mouse melanoma lung metastasis model. Stem Cells 26, 2332–2338 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Stagg, J., Lejeune, L., Paquin, A. & Galipeau, J. Marrow stromal cells for interleukin-2 delivery in cancer immunotherapy. Hum. Gene Ther. 15, 597–608 (2004).
  Article CAS PubMed Google Scholar
• Nakamura, K. et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther. 11, 1155–1164 (2004).
  Article CAS PubMed Google Scholar
• Chen, X. et al. A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs. Mol. Ther. 16, 749–756 (2008).
  Article CAS PubMed Google Scholar
• Danks, M. K. et al. Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma. Cancer Res. 67, 22–25 (2007).
  Article CAS PubMed Google Scholar
• Roger, M. et al. Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. Biomaterials 31, 8393–8401 (2010).
  Article CAS PubMed Google Scholar
• Doshi, N., Zahr, A. S., Bhaskar, S., Lahann, J. & Mitragotri, S. Red blood cell-mimicking synthetic biomaterial particles. Proc. Natl Acad. Sci. USA 106, 21495–21499 (2009). This study described RBC-mimetic synthetic polymer particles that resemble natural RBCs in size, shape, mechanical flexibility as well as oxygen-carrying ability.
  Article CAS PubMed PubMed Central Google Scholar
• Haghgooie, R., Toner, M. & Doyle, P. Squishy non-spherical hydrogel microparticles. Macromol. Rapid Commun. 31, 128–134 (2010).
  CAS PubMed Google Scholar
• Merkel, T. J. et al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc. Natl Acad. Sci. USA 108, 586–591 (2011). This paper demonstrated that particles that possess deformability that is comparable to RBCs exhibit longer circulation times.
  Article CAS PubMed PubMed Central Google Scholar
• Oldenborg, P. A. et al. Role of CD47 as a marker of self on red blood cells. Science 288, 2051–2054 (2000).
  Article CAS PubMed Google Scholar
• Ruoslahti, E., Bhatia, S. N. & Sailor, M. J. Targeting of drugs and nanoparticles to tumors. J. Cell Biol. 188, 759–768 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Yoo, J., Chambers, E. & Mitragotri, S. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. Curr. Pharm. Des. 16, 2298–2307 (2010).
  Article CAS PubMed Google Scholar
• Tsai, R. K. & Discher, D. E. Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J. Cell Biol. 180, 989–1003 (2008). This was the first study to use CD47, a 'marker of self', on synthetic particles to obtain resistance to phagocytosis by macrophages.
  Article CAS PubMed PubMed Central Google Scholar
• Bertram, J. P. et al. Intravenous hemostat: nanotechnology to halt bleeding. Sci. Transl. Med. 1, 11ra22 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Mitragotri, S. & Lahann, J. Physical approaches to biomaterial design. Nature Mater. 8, 15–23 (2009).
  Article CAS Google Scholar
• Kisak, E. T., Coldren, B. & Zasadzinski, J. A. Nanocompartments enclosing vesicles, colloids, and macromolecules via interdigitated lipid bilayers. Langmuir 18, 284–288 (2002).
  Article CAS Google Scholar
• Boyer, C. & Zasadzinski, J. A. Multiple lipid compartments slow vesicle contents release in lipases and serum. ACS Nano 1, 176–182 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Sengupta, S. et al. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature 436, 568–572 (2005).
  Article CAS PubMed Google Scholar
• Kubowicz, S., Baussard, J. & Lutz, J. Multicompartment micelles formed by self-assembly of linear ABC triblock copolymers in aqueous medium. Angew. Chem. Int. Ed. Engl. 44, 5262–5265 (2005).
  Article CAS PubMed Google Scholar
• Li, Z., Kesselman, E., Talmon, Y., Hillmyer, M. A. & Lodge, T. P. Multicompartment micelles from ABC miktoarm stars in water. Science 306, 98–101 (2004).
  Article CAS PubMed Google Scholar
• Utada, A. S. et al. Monodisperse double emulsions generated from a microcapillary device. Science 308, 537–541 (2005).
  Article CAS PubMed Google Scholar
• Nie, Z., Xu, S., Seo, M., Lewis, P. C. & Kumacheva, E. Polymer particles with various shapes and morphologies produced in continuous microfluidic reactors. J. Am. Chem. Soc. 127, 8058–8063 (2005).
  Article CAS PubMed Google Scholar
• Berkland, C., Pollauf, E., Pack, D. W. & Kim, K. Uniform double-walled polymer microspheres of controllable shell thickness. J. Control Release 96, 101–111 (2004).
  Article CAS PubMed Google Scholar
• Roh, K.H., Martin, D. C. & Lahann, J. Biphasic Janus particles with nanoscale anisotropy. Nature Mater. 4, 759–763 (2005). This was the demonstration of a novel technique for synthesizing nanoparticles with biphasic geometry.
  Article CAS Google Scholar
• Bhaskar, S., Hitt, J., Chang, S.W. L. & Lahann, J. Multicompartmental microcylinders. Angew. Chem. Int. Ed. Engl. 48, 4589–4593 (2009).
  Article CAS PubMed Google Scholar
• Dendukuri, D., Gu, S. S., Pregibon, D. C., Hatton, T. A. & Doyle, P. S. Stop-flow lithography in a microfluidic device. Lab Chip 7, 818–828 (2007).
  Article CAS PubMed Google Scholar
• Dendukuri, D., Pregibon, D. C., Collins, J., Hatton, T. A. & Doyle, P. S. Continuous-flow lithography for high-throughput microparticle synthesis. Nature Mater. 5, 365–369 (2006).
  Article CAS Google Scholar
• Gentschev, I. et al. Recombinant attenuated bacteria for the delivery of subunit vaccines. Vaccine 19, 2621–2628 (2001).
  Article CAS PubMed Google Scholar
• Ebensen, T. et al. Bacterial ghosts are an efficient delivery system for DNA vaccines. J. Immunol. 172, 6858–6865 (2004).
  Article CAS PubMed Google Scholar
• Schmidt, U., Gunther, C., Rudolph, R. & Bohm, G. Protein and peptide delivery via engineered polyomavirus-like particles. FASEB J. 15, 1646–1648 (2001).
  Article CAS PubMed Google Scholar